Alterations of coagulation and fibrinolytic and kallikrein-kinin systems in the acute and postacute phases in patients with unstable angina pectoris.
about
Arterial indications for the low molecular weight heparinsRole of ELISA D-dimer test in patients with unstable angina pectoris presenting at the emergency department with a normal electrocardiogramEffect of atorvastatin on haemostasis, fibrinolysis and inflammation in normocholesterolaemic patients with coronary artery disease: a post hoc analysis of data from a prospective, randomized, double-blind study.New advances in the management of acute coronary syndromes: 4. Low-molecular-weight heparins.Circulating levels of plasminogen and oxidized phospholipids bound to plasminogen distinguish between atherothrombotic and non-atherothrombotic myocardial infarction.Admission D-dimer testing for differentiating acute aortic dissection from other causes of acute chest pain.Therapy of unstable angina with the low molecular weight heparins.Role of Factor XII in hemostasis and thrombosis: clinical implications.Ceruloplasmin is a better predictor of the long-term prognosis compared with fibrinogen, CRP, and IL-6 in patients with severe unstable angina.Critical review of unstable angina and non-ST elevation myocardial infarctionDo haemostasis activation markers that predict cardiovascular disease exist?Management of patients with type 2 diabetes after acute coronary syndromes.Cardioprotective actions of peptide hormones in myocardial ischemia.Human plasma kallikrein-kinin system: physiological and biochemical parametersSystemic blood coagulation activation in acute coronary syndromes.Cardioembolic stroke in atrial fibrillation-rationale for preventive closure of the left atrial appendage.Management strategies for a better outcome in unstable coronary artery disease.Mechanisms of cell death in acute myocardial infarction: pathophysiological implications for treatmentThe effects of rosiglitazone on atherosclerotic progression in patients with Type 2 diabetes at high cardiovascular risk.Platelet-dependent thrombin generation in patients with unstable angina pectoris.Tissue factor and tissue factor pathway inhibitor levels in unstable angina patients during short-term low-molecular-weight heparin administration.Determinants of ELISA D-dimer sensitivity for unstable angina pectoris as defined by coronary catheterization.Association between early postoperative coagulation activation and peri-operative myocardial ischaemia in patients undergoing vascular surgery.
P2860
Q24806932-C9EB757B-9878-42F8-A417-FAF07B750165Q28213767-55F07DFD-8EFB-43DD-A1A6-ECE7F8CF045DQ33571435-52E75061-9E16-4949-B21A-4DF396E72CBAQ33576224-3AAECE76-0ECB-46EA-9AC3-5E56156BA7E7Q33597486-FBA37A47-633F-4243-A568-B2E1BFF1CE75Q33645975-7A780DFE-0373-445D-9FA0-35577211EEB7Q34158934-79A6283C-3340-410B-8FC8-99CDB37A9537Q34644690-DC2F5941-DD10-4DD4-8166-ECAEFB97BA5BQ34767602-9F68EE36-C227-4CDA-902E-C00FB5588B85Q35037630-2C08345D-E1A2-432C-970A-4A3D82C507D1Q36030445-9AC637EF-8C16-4603-97EC-594E9CF2365BQ36333931-9739F63E-E933-4F74-8F6C-FA33C9F4A16CQ36827893-F783414D-8CE9-4D53-8A41-B1A19EA021C6Q36998879-BD212223-8678-4B0F-A80B-4DF76F2D65FDQ37116951-5E0B6F3C-B3D1-4E18-AE08-43398E31E82AQ37464600-CEB35A59-DD10-4D6F-A811-90AD60F89421Q40858772-8DE47DA8-6CF0-4D4A-87FC-FD39BBCFD6CBQ42332637-29272E56-927C-4661-95FA-63A660D8801EQ42831071-5E771504-8658-4369-B7D9-DBD7CD912FA7Q43844783-B489741B-4295-4D52-B23C-76007DED3620Q44004556-ABEC8C86-4D04-4A89-A593-CF9BB55D5987Q47426398-32CC042C-63A9-44C4-B251-B42524FDC0ABQ48758198-4F2FA77E-9F42-406B-B80F-720074063423
P2860
Alterations of coagulation and fibrinolytic and kallikrein-kinin systems in the acute and postacute phases in patients with unstable angina pectoris.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Alterations of coagulation and ...... with unstable angina pectoris.
@en
Alterations of coagulation and ...... with unstable angina pectoris.
@nl
type
label
Alterations of coagulation and ...... with unstable angina pectoris.
@en
Alterations of coagulation and ...... with unstable angina pectoris.
@nl
prefLabel
Alterations of coagulation and ...... with unstable angina pectoris.
@en
Alterations of coagulation and ...... with unstable angina pectoris.
@nl
P2093
P1433
P1476
Alterations of coagulation and ...... with unstable angina pectoris.
@en
P2093
P304
P356
10.1161/01.CIR.91.10.2520
P407
P577
1995-05-01T00:00:00Z